麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida鈥檚 KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida鈥檚 KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, May 20 2016

Full Issue

Genetic Testing Company Myriad Accused Of Withholding Data From Patients

A complaint filed on behalf of four patients alleges that the company is not providing the patients with access to their full test results. Myriad says that genetic information is not covered by HIPAA rules. Meanwhile, scientists are closer to identifying genes that could lead to "designer babies."

Genetic testing company Myriad Genetics, the defendant in a landmark Supreme Court case over gene patents, is back in the spotlight 鈥 this time, for withholding genetic data from patients. Myriad held patents on the BRCA1 and BRCA2 genes until 2013, and tested more than 1 million patients for variations in those genes that might increase a person鈥檚 risk of breast, ovarian, prostate, and other cancers. Though Myriad no longer holds the patents on those genes, it still holds patients鈥 data, and has been resistant to sharing it with researchers or public databases. (Samuel, 5/19)

In the futuristic movie 鈥淕attaca,鈥 those in the ruling class are genetically engineered to be a physically perfect version of their parents. They are as thin and tall as models, with perfect cheekbones, square jaws and thick, glossy hair. Think of stars Uma Thurman and Jude Law. When the movie came out in 1997, this idea of 鈥渄esigner babies鈥 was still far-fetched. DNA analysis was still in its early stages and the world was still years away from sequencing the first human genome, much less a particular gene鈥檚 function. But in the more than 20 years that have passed, our understanding of our own DNA and how it works has exploded, and scientists have discovered a great number of genes that control our physical appearance. (Cha, 5/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优